Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
14,866
datasets available to search
ShareScore release 0.9.0
Dataset results
14,866 results for “cancer cell”
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
ClinicalTrials.gov study NCT00076310. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.
ClinicalTrials.gov study NCT02968979. IPD Sharing: NO. Countries: 1. Publications: 1.
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-
ClinicalTrials.gov study NCT04639245. IPD Sharing: NO. Countries: 1. Publications: 1.
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
ClinicalTrials.gov study NCT03322540. IPD Sharing: NO. Countries: 18. Publications: 1.
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04735068. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
ClinicalTrials.gov study NCT02267603. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00323869. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
ClinicalTrials.gov study NCT03037385. IPD Sharing: NO. Countries: 13. Publications: 8.
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
ClinicalTrials.gov study NCT02111850. IPD Sharing: NO. Countries: 1. Publications: 3.
Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04712903. IPD Sharing: YES. Countries: 1. Publications: 1.
Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00402051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
ClinicalTrials.gov study NCT01130519. IPD Sharing: YES. Countries: 1. Publications: 4.
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
ClinicalTrials.gov study NCT00711594. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04475939. IPD Sharing: YES. Countries: 27. Publications: 1.
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
ClinicalTrials.gov study NCT01057589. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02659059. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
ClinicalTrials.gov study NCT00520130. IPD Sharing: NO. Countries: 1. Publications: 6.
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
ClinicalTrials.gov study NCT01967823. IPD Sharing: NO. Countries: 1. Publications: 3.
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01625234. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00600015. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.